{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1047.372","meta":{"versionId":"19","lastUpdated":"2016-12-27T01:00:03.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.372","version":"20161227","name":"Cancer Medication Doxorubicin","status":"active","date":"2016-12-27T01:00:03-05:00","publisher":"Oncology Nursing Society Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"3639","display":"Doxorubicin"}]}]},"expansion":{"identifier":"urn:uuid:4920dd9a-d944-436f-bd4d-a711bc9efd9d","timestamp":"2022-06-10T05:25:16-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"3639","display":"doxorubicin"}]}}